Agenda (in Eastern Time):

10:00 — Welcome and Roll Call

10:20 — Updates on Work Groups

11:00 — COVID-19 Vaccines

• Introduction
• Epidemiology
• Effectiveness
• Safety
• Coverage and Implementation
• Evidence to Recommendations)

1:00 — Lunch

1:30 — Agency Updates

2:00 — RSV Vaccines (Maternal/Pediatric)

• Introduction
• Updates on uptake of maternal vaccine and nirsevimab
• Updates on the impact and epidemiology of maternal vaccine and nirsevimab
• Updates on safety of maternal vaccine and nirsevimab
• Updates and summary of the Evidence to Recommendation
• Framework for clesrovimab
• Updates on clinical considerations for clesrovimab
• Proposed Recommendations
• Updates to RSV vaccine VFC resolution

4:00 — Break

4:15 — Public Comment

5:00 — Votes

• RSV Vaccines (Maternal/Pediatric)
• RSV Vaccines (VFC)

5:30 — Adjourn